151. Regression of murine lung tumors by the let-7 microRNA
- Author
-
Frank J. Slack, Pedro P. Medina, Robert J. Homer, David F.M. Brown, Michael Omotola, Jason F. Wiggins, Joanne B. Weidhaas, Lynnsie Ruffino, Kevin Kelnar, Andreas G. Bader, and Phong Trang
- Subjects
Cancer Research ,Lung Neoplasms ,Mice, SCID ,law.invention ,Mice ,0302 clinical medicine ,law ,Mice, Inbred NOD ,Carcinoma, Non-Small-Cell Lung ,Non-Small-Cell Lung ,Lung ,Cancer ,0303 health sciences ,Tumor ,Reverse Transcriptase Polymerase Chain Reaction ,Lung Cancer ,3. Good health ,Tumor Burden ,microRNAs ,Let-7 ,medicine.anatomical_structure ,5.1 Pharmaceuticals ,030220 oncology & carcinogenesis ,Biotechnology ,Clinical Sciences ,Oncology and Carcinogenesis ,Biology ,SCID ,Article ,Cell Line ,03 medical and health sciences ,let-7 ,In vivo ,Cell Line, Tumor ,microRNA ,medicine ,Carcinoma ,Genetics ,Animals ,Humans ,RNA, Antisense ,Oncology & Carcinogenesis ,Antisense ,Lung cancer ,K-ras ,Molecular Biology ,030304 developmental biology ,Base Sequence ,medicine.disease ,Xenograft Model Antitumor Assays ,lung cancer ,Cell culture ,Immunology ,Cancer research ,Suppressor ,Inbred NOD ,RNA - Abstract
MicroRNAs (miRNAs) have recently emerged as an important new class of cellular regulators that control various cellular processes and are implicated in human diseases, including cancer. Here, we show that loss of let-7 function enhances lung tumor formation in vivo, strongly supporting the hypothesis that let-7 is a tumor suppressor. Moreover, we report that exogenous delivery of let-7 to established tumors in mouse models of non-small-cell lung cancer (NSCLC) significantly reduces the tumor burden. These results demonstrate the therapeutic potential of let-7 in NSCLC and point to miRNA replacement therapy as a promising approach in cancer treatment.
- Published
- 2010